Preclin Biosystems
Epalinges, Vaud, Switzerland
About Preclin Biosystems
Preclin Biosystems AG offers a comprehensive in vivo preclinical testing platform for the identification and validation of lead candidate therapeutics. They specialize in preclinical models of chronic inflammatory and infectious diseases. They also offer a fully customizable service ensuring your development goals are achieved. Preclin Biosystems AG provides the expertise to unravel a drug mechanism of action, optimal route and regime of administration, and efficacy in defined disease indications.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $115.4K
- Funding stage: Seed
- Last round: Pre-Seed (Oct 2008)
- Website: preclinbiosystems.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/preclin-biosystems-2560033 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.